Physician profile
Aasma Shaukat
NPI 1073529871
$41,029.66
in general payments reported to CMS, 2019-2025
10 companies · $7,936 in 2025
The $7,936 reported for 2025 was more than what 92% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $3,500 · 2021: $21K · 2022: $2,897 · 2023: $148 · 2024: $5,930 · 2025: $7,936.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,750 · Honoraria: $3,500 · Travel and Lodging: $1,875 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Education: $850 · Food and Beverage: $538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,750.00 |
| Honoraria | $3,500.00 |
| Travel and Lodging | $1,875.35 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Education | $850.00 |
| Food and Beverage | $537.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $23,369.32 | 2021-2022 | |
| Iterative Scopes, INC. | $5,965.60 | 2024-2025 | Skout |
| Roche Molecular Systems, INC. | $4,250.13 | 2025 | |
| Polymedco, LLC | $3,500.00 | 2025 | |
| Covidien LP | $3,500.00 | 2020 | |
| Janssen Biotech, INC. | $147.09 | 2022 | |
| Janssen Scientific Affairs, LLC | $134.87 | 2025 | Tremfya |
| Boston Scientific Corporation | $104.30 | 2023 | Exalt Model D |
| Exact Sciences Corporation | $43.55 | 2023 | Cologuard Collection Kit |
| Micro-Tech Endoscopy USA, INC. | $14.80 | 2025 | Coag Grasper |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aasma Shaukat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.